Other options usually better than benzodiazepines in alleviating dyspnoea, sleeping problems and anxiety in COPD patients

被引:1
作者
Fenton, Caroline [1 ]
Kang, Connie [1 ]
机构
[1] Springer Nat, Private Bag 65901, Auckland 0754, New Zealand
关键词
OBSTRUCTIVE PULMONARY-DISEASE; ADULTS; METAANALYSIS; RESPIRATION; RECEPTORS; MORTALITY; INSOMNIA; MODERATE; OUTCOMES; TRENDS;
D O I
10.1007/s40267-020-00787-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic obstructive pulmonary disease (COPD) is common, especially in older people, and causes progressive dyspnoea that is often accompanied by anxiety and depression. Benzodiazepines (BZDs) are regularly prescribed to COPD patients but can cause significant respiratory adverse events. There are usually better treatment alternatives, such as pulmonary rehabilitation and treatment with antidepressants. The increasing prescription of BZDs with age is concerning, particularly as COPD becomes more prevalent.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 35 条
  • [1] [Anonymous], 2018, LECTOPAM BROMAZEPAM
  • [2] [Anonymous], 2018, MOGADON NITRAZEPAM T
  • [3] [Anonymous], 2017, ALPRAZOLAM TABLETS U
  • [4] [Anonymous], 2019, KLONOPIN CLONAZEPAM
  • [5] [Anonymous], 2020, Global Strategy for the Diagnosis, Management and Prevention of COPD
  • [6] [Anonymous], 2019, CHLORDIAZEPOXIDE HYD
  • [7] [Anonymous], 2020, LUNESTA ESZOPICLONE
  • [8] [Anonymous], 2019, TRIAZOLAM TABLETS US
  • [9] [Anonymous], 2018, FLURAZEPAM HYDROCHLO
  • [10] [Anonymous], 2019, VALIUM DIAZEPAM TABL